NCT04254211View on ClinicalTrials.gov

Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Predictors for Adverse Events in EVAR

CompletedOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

February 1, 2019

Study Completion Date

November 1, 2019

Conditions
Inflammation in EVAR
Interventions
OTHER

NLR

neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR)

Trial Locations (1)

41110

Univeristy of Thessaly, Larissa

All Listed Sponsors
lead

University of Thessaly

OTHER

NCT04254211 - Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Predictors for Adverse Events in EVAR | Biotech Hunter | Biotech Hunter